Classification
- Anatomical main groupLAntineoplastic and immunomodulating agents
- Therapeutic subgroupL01Antineoplastic agents
- Pharmacological subgroupL01F
- Chemical subgroupL01FXOther monoclonal antibodies and antibody drug conjugates
- Chemical substanceL01FX12Tafasitamab
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Brazil
Anvisa · 1 registration
Canada
Health Canada · 1 registration
Spain
AEMPS · 1 registration
European Union
EMA · 1 registration
At a glance
- ATC code
- L01FX12
- Registers
- 7
- Registrations
- 7
- With their own page
- 7
- Companies
- 4
All medicines with Tafasitamab
Human medicines from every register that match Tafasitamab by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
7 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Monjuvi | United States | 12MG/KG | solution | Marketed | Morphosys US INC |
| Minjuvi | European Union | Authorised | Incyte Biosciences Distribution B.V. | ||
| Minjuvi 200 MG Polvo Para Concentrado Para Solucion Para Perfusion | Spain | 200 mg | polvo para concentrado para solución para perfusión | Marketed | Incyte Biosciences Distribution B.V. |
| Minjuvi 200 mg poeder voor concentraat voor oplossing voor infusie | Netherlands | Poeder voor concentraat voor oplossing voor infusie | Authorised | Incyte Biosciences Distribution B.V. | |
| Minjuvi | Canada | 200 MG / VIAL | Powder For Solution | Marketed | Incyte Corporation |
| Minjuvi | Brazil | Authorised | United Medical Ltda | ||
| Minjuvi | Croatia | Not marketed |